Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C20H27NO2 |
| Molecular Weight | 313.4339 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1OC)C(CCCC2=CC=CC=C2)N(C)C
InChI
InChIKey=HEFVRVOEBZDOJU-UHFFFAOYSA-N
InChI=1S/C20H27NO2/c1-21(2)18(12-8-11-16-9-6-5-7-10-16)17-13-14-19(22-3)20(15-17)23-4/h5-7,9-10,13-15,18H,8,11-12H2,1-4H3
Vetrabutine is a spasmolytic agent. As a musculotropic spasmolytic agent vatrabutine was reported to act directly on the smooth muscle fibers and to have no neurotropic activity. In pigs, its activity was specific to the uterine body and cervical musculature where it acted on the myometrial cells, sealing off the membrane against the passage of potassium ions, thereby increasing membrane potential and lowering tonus. Vetrabutine was of moderate acute oral toxicity. Vetributine hydrochloride has been used in human medicine as a spasmolytic agent in obstetrics.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29698
Created by
admin on Wed Apr 02 09:43:42 GMT 2025 , Edited by admin on Wed Apr 02 09:43:42 GMT 2025
|
||
|
WHO-VATC |
QG02CA90
Created by
admin on Wed Apr 02 09:43:42 GMT 2025 , Edited by admin on Wed Apr 02 09:43:42 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
I3E2J32F37
Created by
admin on Wed Apr 02 09:43:42 GMT 2025 , Edited by admin on Wed Apr 02 09:43:42 GMT 2025
|
PRIMARY | |||
|
4010
Created by
admin on Wed Apr 02 09:43:42 GMT 2025 , Edited by admin on Wed Apr 02 09:43:42 GMT 2025
|
PRIMARY | |||
|
SUB00046MIG
Created by
admin on Wed Apr 02 09:43:42 GMT 2025 , Edited by admin on Wed Apr 02 09:43:42 GMT 2025
|
PRIMARY | |||
|
m11438
Created by
admin on Wed Apr 02 09:43:42 GMT 2025 , Edited by admin on Wed Apr 02 09:43:42 GMT 2025
|
PRIMARY | Merck Index | ||
|
C73164
Created by
admin on Wed Apr 02 09:43:42 GMT 2025 , Edited by admin on Wed Apr 02 09:43:42 GMT 2025
|
PRIMARY | |||
|
100000079083
Created by
admin on Wed Apr 02 09:43:42 GMT 2025 , Edited by admin on Wed Apr 02 09:43:42 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104458
Created by
admin on Wed Apr 02 09:43:42 GMT 2025 , Edited by admin on Wed Apr 02 09:43:42 GMT 2025
|
PRIMARY | |||
|
DTXSID90863262
Created by
admin on Wed Apr 02 09:43:42 GMT 2025 , Edited by admin on Wed Apr 02 09:43:42 GMT 2025
|
PRIMARY | |||
|
3735-45-3
Created by
admin on Wed Apr 02 09:43:42 GMT 2025 , Edited by admin on Wed Apr 02 09:43:42 GMT 2025
|
PRIMARY | |||
|
111122
Created by
admin on Wed Apr 02 09:43:42 GMT 2025 , Edited by admin on Wed Apr 02 09:43:42 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)